Spero Therapeutics, Inc. - COM (SPRO)

Historical Portfolio Holders from Q4 2017 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
12.3M
Holdings value Q3 2024
$16.5M
Value change Q3 2024
-$2.04M
Grand Portfolio weight change Q3 2024
0%
Number of holders
45
Number of buys Q3 2024
9
Number of sells Q3 2024
-18
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 12.3M $16.5M -$2.04M $1.34 45
2024 Q2 13.9M $18M +$23.1K $1.30 46
2024 Q1 13.7M $23.6M -$10.7K $1.72 54
2023 Q4 13.3M $19.6M +$232K $1.47 44
2023 Q3 14.2M $17.2M -$231K $1.21 51
2023 Q2 14.4M $20.8M +$225K $1.45 54
2023 Q1 14.2M $20.6M -$11.5K $1.45 44
2022 Q4 14.2M $24.6M -$11.5M $1.73 57
2022 Q3 19.9M $39.7M +$135K $2.00 60
2022 Q2 20.9M $15.5M -$13.7M $0.74 60
2022 Q1 20.2M $176M +$3.32M $8.70 96
2021 Q4 19.8M $317M +$1.75M $16.01 83
2021 Q3 18.4M $338M +$16.5M $18.41 88
2021 Q2 16.1M $225M -$15.1M $13.96 82
2021 Q1 18.5M $273M +$11.2M $14.72 89
2020 Q4 19.1M $370M +$23.9M $19.39 88
2020 Q3 16.8M $187M +$55.4M $11.16 78
2020 Q2 11.8M $159M +$6.8M $13.53 76
2020 Q1 11.5M $93.2M +$5.36M $8.08 60
2019 Q4 10.8M $104M +$4.18M $9.61 61
2019 Q3 10.4M $110M -$2.91M $10.60 59
2019 Q2 10.6M $122M +$15.8M $11.51 60
2019 Q1 9.27M $119M +$3.62M $12.81 53
2018 Q4 9.1M $56M -$16.9M $6.15 50
2018 Q3 10.7M $113M +$24.5M $10.51 51
2018 Q2 8.12M $119M +$30.5K $14.67 42
2018 Q1 7.7M $110M -$578K $14.25 34
2017 Q4 7.76M $91.2M +$91M $11.75 36